|
G
|
Crp
|
C-reactive protein
|
decreases expression
|
ISO
|
Colesevelam Hydrochloride results in decreased expression of CRP protein
|
CTD |
PMID:16616026 |
|
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions increases expression
|
ISO
|
Colesevelam Hydrochloride promotes the reaction [Simvastatin results in increased expression of HMGCR mRNA] Colesevelam Hydrochloride results in increased expression of HMGCR mRNA
|
CTD |
PMID:22120639 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
G
|
Ldlr
|
low density lipoprotein receptor
|
increases expression
|
ISO
|
Colesevelam Hydrochloride results in increased expression of LDLR mRNA
|
CTD |
PMID:22120639 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
|
G
|
Dek
|
DEK proto-oncogene
|
decreases secretion
|
ISO
|
DEK protein results in decreased secretion of Polyglutamic Acid
|
CTD |
PMID:28558019 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,787,139...17,810,122
|
|
G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
affects localization
|
EXP
|
Polyglutamic Acid affects the localization of HSPA8 protein
|
CTD |
PMID:10469394 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
decreases activity
|
ISO
|
Polyynes results in decreased activity of ABCB1 protein
|
CTD |
PMID:18425719 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
|
G
|
Acp5
|
acid phosphatase 5, tartrate resistant
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of ACP5 mRNA
|
CTD |
PMID:15585240 |
|
NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:28,939,985...28,943,929
|
|
G
|
Ascl1
|
achaete-scute family bHLH transcription factor 1
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of ASCL1 mRNA
|
CTD |
PMID:23203475 |
|
NCBI chr 7:23,790,642...23,793,509
Ensembl chr 7:23,790,360...23,798,231
|
|
G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of BGLAP protein
|
CTD |
PMID:10225790 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of CAT protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] which results in decreased expression of CAT protein]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT protein]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] which results in decreased expression of CAT protein
|
CTD |
PMID:38180308 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of COL1A1 mRNA
|
CTD |
PMID:11216681 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Csf2
|
colony stimulating factor 2
|
affects secretion
|
ISO
|
Polyethylene affects the secretion of CSF2 protein
|
CTD |
PMID:15046894 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of FOS mRNA
|
CTD |
PMID:15585240 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Foxg1
|
forkhead box G1
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of FOXG1 mRNA
|
CTD |
PMID:23203475 |
|
NCBI chr 6:72,401,582...72,404,392
Ensembl chr 6:72,394,239...72,427,392
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of GPT protein
|
CTD |
PMID:38180308 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Hes5
|
hes family bHLH transcription factor 5
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of HES5 mRNA
|
CTD |
PMID:23203475 |
|
NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 protein]
|
CTD |
PMID:38180308 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
Polyethylene analog promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
|
CTD |
PMID:10602080 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
ISO
|
Polyethylene results in increased expression of IL6 mRNA; Polyethylene results in increased expression of IL6 protein [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of IL6 protein; Polyethylene analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
|
CTD |
PMID:10602080 PMID:11771709 PMID:38180308 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein]
|
CTD |
PMID:38180308 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
G
|
Litaf
|
lipopolysaccharide-induced TNF factor
|
increases expression
|
ISO
|
Polyethylene results in increased expression of LITAF mRNA
|
CTD |
PMID:17408380 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:5,163,242...5,199,930
|
|
G
|
Neurod1
|
neuronal differentiation 1
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of NEUROD1 mRNA
|
CTD |
PMID:23203475 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of NFE2L2 mRNA; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]
|
CTD |
PMID:38180308 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Notch1
|
notch receptor 1
|
decreases expression
|
ISO
|
Polyethylene results in decreased expression of NOTCH1 mRNA
|
CTD |
PMID:23203475 |
|
NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased phosphorylation of RELA protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RELA protein]
|
CTD |
PMID:38180308 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
increases expression
|
ISO
|
Polyethylene results in increased expression of SRC mRNA
|
CTD |
PMID:15585240 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
G
|
Tnf
|
tumor necrosis factor
|
increases expression multiple interactions affects secretion
|
ISO
|
Polyethylene results in increased expression of TNF mRNA [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of TNF protein; Polyethylene analog inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Polyethylene affects the secretion of TNF protein Etidronic Acid inhibits the reaction [Polyethylene affects the secretion of TNF protein]; ibandronic acid inhibits the reaction [Polyethylene affects the secretion of TNF protein]
|
CTD |
PMID:10413987 PMID:10602080 PMID:17408380 PMID:38180308 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf11b
|
TNF receptor superfamily member 11B
|
decreases expression decreases secretion
|
ISO
|
Polyethylene results in decreased expression of TNFRSF11B protein Polyethylene results in decreased secretion of TNFRSF11B protein
|
CTD |
PMID:15046894 PMID:15585240 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:87,456,319...87,485,075
|
|
G
|
Tnfsf11
|
TNF superfamily member 11
|
affects secretion increases secretion
|
ISO
|
Polyethylene affects the secretion of TNFSF11 protein Polyethylene results in increased secretion of TNFSF11 protein
|
CTD |
PMID:15046894 PMID:15585240 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
|
|
|
G
|
Alox5
|
arachidonate 5-lipoxygenase
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of ALOX5 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
G
|
Anxa2
|
annexin A2
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of ANXA2 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631
|
|
G
|
Ccna1
|
cyclin A1
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of CCNA1 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:141,382,468...141,393,300
|
|
G
|
Cd14
|
CD14 molecule
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of CD14 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
G
|
Cd27
|
CD27 molecule
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of CD27 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:159,716,935...159,721,823
|
|
G
|
Cdk1
|
cyclin-dependent kinase 1
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of CDK1 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
|
|
G
|
Cdk4
|
cyclin-dependent kinase 4
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of CDK4 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
|
|
G
|
Dbf4
|
DBF4-CDC7 kinase regulatory subunit
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of DBF4 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:26,631,514...26,656,562
|
|
G
|
Dusp1
|
dual specificity phosphatase 1
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of DUSP1 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644
|
|
G
|
Gmps
|
guanine monophosphate synthase
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of GMPS mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:150,587,854...150,648,986
|
|
G
|
Hsp90b1
|
heat shock protein 90 beta family member 1
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of HSP90B1 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:22,997,962...23,012,293
|
|
G
|
Hspd1
|
heat shock protein family D (Hsp60) member 1
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of HSPD1 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
|
|
G
|
Ik
|
IK cytokine
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of IK mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463
|
|
G
|
Il9r
|
interleukin 9 receptor
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of IL9R mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,936,156...15,947,613
|
|
G
|
Met
|
MET proto-oncogene, receptor tyrosine kinase
|
affects expression
|
ISO
|
poly(propyleneimine) analog affects the expression of MET mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
|
|
G
|
Pccb
|
propionyl-CoA carboxylase subunit beta
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of PCCB mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 8:101,591,218...101,641,213
Ensembl chr 8:110,469,934...110,520,187
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of PCNA mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Psma4
|
proteasome 20S subunit alpha 4
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of PSMA4 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:64,236,783...64,243,979
|
|
G
|
Psmb4
|
proteasome 20S subunit beta 4
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of PSMB4 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287
|
|
G
|
Rpa3
|
replication protein A3
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of RPA3 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:37,270,966...37,274,183
|
|
G
|
Rpl8
|
ribosomal protein L8
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of RPL8 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:110,506,800...110,509,103 Ensembl chr 3:110,506,800...110,509,103
|
|
G
|
Rxra
|
retinoid X receptor alpha
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of RXRA mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
|
|
G
|
Smarca4
|
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of SMARCA4 mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 8:28,438,370...28,535,071
Ensembl chr 8:28,443,810...28,535,070
|
|
G
|
Tgfa
|
transforming growth factor alpha
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of TGFA mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
|
|
G
|
Tpr
|
translocated promoter region, nuclear basket protein
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of TPR mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr13:64,974,419...65,037,604
Ensembl chr13:64,974,419...65,037,602
|
|
G
|
Tubb4a
|
tubulin, beta 4A class IVa
|
increases expression
|
ISO
|
poly(propyleneimine) analog results in increased expression of TUBB4A mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 9:2,004,836...2,012,281
Ensembl chr 9:2,004,840...2,012,286
|
|
G
|
Ywhaq
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
decreases expression
|
ISO
|
poly(propyleneimine) analog results in decreased expression of YWHAQ mRNA
|
CTD |
PMID:16308212 |
|
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:46,664,358...46,694,875
|
|
|
G
|
C3
|
complement C3
|
increases expression
|
ISO
|
styrofoam analog results in increased expression of C3 protein
|
CTD |
PMID:19428933 |
|
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
|
|
G
|
C5
|
complement C5
|
increases expression
|
ISO
|
styrofoam analog results in increased expression of C5 protein
|
CTD |
PMID:19428933 |
|
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions affects activity
|
ISO
|
styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] styrofoam analog affects the activity of CYP1A2 protein
|
CTD |
PMID:19909766 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Cyp2d4
|
cytochrome P450, family 2, subfamily d, polypeptide 4
|
decreases activity multiple interactions
|
ISO
|
styrofoam analog results in decreased activity of CYP2D6 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2D6 protein]
|
CTD |
PMID:19909766 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
|
|
G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
decreases activity multiple interactions
|
ISO
|
styrofoam analog results in decreased activity of CYP3A4 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP3A4 protein]
|
CTD |
PMID:19909766 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
G
|
Itgam
|
integrin subunit alpha M
|
increases expression
|
ISO
|
styrofoam analog results in increased expression of ITGAM protein
|
CTD |
PMID:19428933 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
G
|
Pf4
|
platelet factor 4
|
increases secretion
|
ISO
|
styrofoam analog results in increased secretion of PF4 protein
|
CTD |
PMID:19428933 |
|
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392
|
|
G
|
Ppbp
|
pro-platelet basic protein
|
increases secretion
|
ISO
|
styrofoam analog results in increased secretion of PPBP protein
|
CTD |
PMID:19428933 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,586,495...17,587,299
|
|
G
|
Selp
|
selectin P
|
increases expression
|
ISO
|
styrofoam results in increased expression of SELP protein
|
CTD |
PMID:21123846 |
|
NCBI chr13:79,009,379...79,044,994
Ensembl chr13:79,009,475...79,044,987
|
|
|
G
|
Angpt1
|
angiopoietin 1
|
decreases expression
|
ISO
|
Polyvinyl Chloride results in decreased expression of ANGPT1 mRNA
|
CTD |
PMID:12809767 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:75,418,218...75,668,696
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of CAT protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] which results in decreased expression of CAT protein]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT protein]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] which results in decreased expression of CAT protein
|
CTD |
PMID:38180308 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of GPT protein
|
CTD |
PMID:38180308 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 protein]
|
CTD |
PMID:38180308 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of IL6 protein
|
CTD |
PMID:38180308 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Keap1
|
Kelch-like ECH-associated protein 1
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein]
|
CTD |
PMID:38180308 |
|
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of NFE2L2 mRNA; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]
|
CTD |
PMID:38180308 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased phosphorylation of RELA protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RELA protein]
|
CTD |
PMID:38180308 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO
|
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of TNF protein
|
CTD |
PMID:38180308 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
|
G
|
App
|
amyloid beta precursor protein
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased expression of APP protein
|
CTD |
PMID:35697184 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
G
|
Atp5mc2
|
ATP synthase membrane subunit c locus 2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 7:133,791,341...133,799,713
Ensembl chr 7:135,669,848...135,678,231
|
|
G
|
Bola3
|
bolA family member 3
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:117,410,680...117,420,491
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] affects the expression of CASP3 protein; [Silver co-treated with Povidone] results in decreased expression of CASP3 mRNA
|
CTD |
PMID:27387714 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] results in decreased expression of CDKN1A mRNA; [Silver co-treated with Povidone] results in decreased expression of CDKN1A protein
|
CTD |
PMID:27387714 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Col8a1
|
collagen type VIII alpha 1 chain
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:56,369,868...56,376,229
|
|
G
|
Cox17
|
cytochrome c oxidase copper chaperone COX17
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of COX17 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr11:62,400,733...62,406,507
Ensembl chr11:75,906,248...75,912,019
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of CYP1A1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Dad1
|
defender against cell death 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of DAD1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287
|
|
G
|
Dlg4
|
discs large MAGUK scaffold protein 4
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in decreased expression of DLG4 protein
|
CTD |
PMID:35697184 |
|
NCBI chr10:55,239,397...55,267,780
Ensembl chr10:55,236,869...55,265,839
|
|
G
|
Gbp2
|
guanylate binding protein 2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of GBP2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:234,008,590...234,021,810
|
|
G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] results in increased expression of H2AX protein modified form
|
CTD |
PMID:27387714 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of HMOX1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Ifi47
|
interferon gamma inducible protein 47
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of IFI47 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr10:33,297,618...33,305,248
Ensembl chr10:33,776,399...33,806,372
|
|
G
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of IFIT3 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:241,526,880...241,532,521
|
|
G
|
Lims1
|
LIM zinc finger domain containing 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,852,996...26,961,606
|
|
G
|
Lmnb2
|
lamin B2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of LMNB2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:9,440,128...9,459,342
|
|
G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in decreased expression of MAP2 protein
|
CTD |
PMID:35697184 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK1 protein
|
CTD |
PMID:21729742 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK3 protein
|
CTD |
PMID:21729742 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mdm2
|
MDM2 proto-oncogene
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA
|
CTD |
PMID:27387714 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791
|
|
G
|
Mt1a
|
metallothionein 1A
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] affects the expression of MT1A mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
|
|
G
|
Nfix
|
nuclear factor I X
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of NFIX mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092
|
|
G
|
Nqo1
|
NAD(P)H quinone dehydrogenase 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of NQO1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
|
|
G
|
Nrm
|
nurim
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,882,369...2,896,605
|
|
G
|
Nuak2
|
NUAK family kinase 2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr13:43,753,454...43,770,604
Ensembl chr13:46,305,975...46,322,748
|
|
G
|
Ocln
|
occludin
|
affects expression
|
ISO
|
Povidone affects the expression of OCLN mRNA
|
CTD |
PMID:19729060 |
|
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
|
|
G
|
Pink1
|
PTEN induced kinase 1
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased expression of PINK1 protein
|
CTD |
PMID:35697184 |
|
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950
|
|
G
|
Ppargc1a
|
PPARG coactivator 1 alpha
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in decreased expression of PPARGC1A protein
|
CTD |
PMID:35697184 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
|
|
G
|
Prkn
|
parkin RBR E3 ubiquitin protein ligase
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased expression of PRKN protein
|
CTD |
PMID:35697184 |
|
NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304
|
|
G
|
Prpf38b
|
pre-mRNA processing factor 38B
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of PRPF38B mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:199,241,313...199,250,338
|
|
G
|
Prr13
|
proline rich 13
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of PRR13 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:135,470,933...135,474,579
|
|
G
|
Psenen
|
presenilin enhancer gamma secretase subunit
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of PSENEN mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:94,942,225...94,943,752
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of PTGS2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Ptk2
|
protein tyrosine kinase 2
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased activity of PTK2 protein
|
CTD |
PMID:21729742 |
|
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:107,015,733...107,172,091
|
|
G
|
Rab14
|
RAB14, member RAS oncogene family
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of RAB14 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 3:18,501,953...18,523,253
Ensembl chr 3:38,901,400...38,912,273
|
|
G
|
Rbm25l1
|
RNA binding motif protein 25-like 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of RBM25L1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr10:10,267,026...10,270,510
Ensembl chr10:10,773,546...10,779,138
|
|
G
|
Samd9l
|
sterile alpha motif domain containing 9 like
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of SAMD9L mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:32,222,623...32,331,067
|
|
G
|
Selenow
|
selenoprotein W
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of SELENOW mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:85,727,632...85,732,703
|
|
G
|
Slc5a3
|
solute carrier family 5 member 3
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of SLC5A3 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] results in increased expression of SOD2 mRNA; [Silver co-treated with Povidone] results in increased expression of SOD2 protein
|
CTD |
PMID:27387714 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
G
|
Sparc
|
secreted protein acidic and cysteine rich
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268
|
|
G
|
Stat2
|
signal transducer and activator of transcription 2
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of STAT2 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:1,287,024...1,303,459
|
|
G
|
Sv2b
|
synaptic vesicle glycoprotein 2b
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of SV2B mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:138,388,266...138,562,258
|
|
G
|
Syp
|
synaptophysin
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased expression of SYP protein
|
CTD |
PMID:35697184 |
|
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:17,521,348...17,536,984
|
|
G
|
Tiparp
|
TCDD-inducible poly(ADP-ribose) polymerase
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:152,063,751...152,090,406
|
|
G
|
Tmtc3
|
transmembrane O-mannosyltransferase targeting cadherins 3
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of TMTC3 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 7:35,264,886...35,310,010
Ensembl chr 7:37,151,456...37,196,540
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO
|
[Silver co-treated with Povidone] affects the phosphorylation of TP53 protein; [Silver co-treated with Povidone] results in decreased expression of TP53 mRNA; [Silver co-treated with Povidone] results in decreased expression of TP53 protein
|
CTD |
PMID:27387714 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Trappc1
|
trafficking protein particle complex subunit 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in decreased expression of TRAPPC1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,544,262...54,546,140
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO
|
[Silver Compounds co-treated with Povidone] results in increased expression of VEGFA protein
|
CTD |
PMID:21729742 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
G
|
Wdfy1
|
WD repeat and FYVE domain containing 1
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr 9:81,034,852...81,092,823
Ensembl chr 9:88,489,227...88,541,186
|
|
G
|
Zfhx3
|
zinc finger homeobox 3
|
multiple interactions
|
EXP
|
[Silver analog co-treated with Povidone] results in increased expression of ZFHX3 mRNA
|
CTD |
PMID:25194297 |
|
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:53,551,488...53,795,664
|
|